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ABSTRACT
Objective: Currently, there is no EQ-5D value set for Poland. The primary
objective of this study was to elicit EQ-5D Polish values using the time
trade-off (TTO) method.
Methods: Face-to-face interviews with visitors of inpatients in eight
medical centers in Warsaw, Skierniewice, and Puławy were carried out by
trained interviewers. Quota sampling was used to achieve a representative
sample of the Polish population with regard to age and sex. Modiﬁed
protocol from the Measurement and Value of Health study was used. Each
respondent ranked 10 health states and valued 4 health states using the
visual analog scale and 23 using the TTO. Mean and variance stability
tests were performed to determine whether using a larger number of health
states per respondent would yield credible results. Modeling included
random effects and random parameters models.
Results: Between February and May 2008, 321 interviews were per-
formed. Modeling based on 6777 valuations resulted in an additive model
with all coefﬁcients statistically signiﬁcant, R2 equal to 0.45, and value
-0.523 for the worst possible health state. Means and variance did not
differ signiﬁcantly for states valued in the middle and at the end of the
TTO exercise.
Conclusions: This is the ﬁrst EQ-5D value set based on TTO in Central
and Eastern Europe so far. Because the values differ considerably from
those elicited in Western European countries, its use should be recom-
mended for studies in Poland. Increasing the number of health states that
each respondent is asked to value using TTO seems feasible and justiﬁable.
Keywords: EQ-5D, Poland, quality-adjusted life-years, social value set,
utility.
Introduction
Economic evaluation of health technologies in the cost–utility
analysis framework aims at providing maximal utility—as per-
ceived by a given society—within a limited budget, and thus
should be based on social preferences that are to be satisﬁed. The
EQ-5D questionnaire is a widely known tool that can be used to
elicit social preferences [1].
The EQ-5D was translated into Polish in 1997, after the
EuroQol Group guidelines and in interaction with EuroQol
translation review members [2]. This version is currently used in
clinical research conducted in Poland. The main limitation
against the wider application of the Polish EQ-5D in clinical and
pharmacoeconomic studies in Poland is the lack of either popu-
lation norms or a national EQ-5D value set. As a result, the
Agency for Health Technology Assessment in Poland (AHTAPol)
has been recommending the use of the EQ-5D European value set
[3]. This value set was derived using the visual analog scale (VAS)
methodology developed during the EuroQol BIOMED Research
Programme funded by the European Union (1998–2001) [4].
This might not be an optimal choice, as in health economics,
the preferred outcome measure is quality-adjusted life-years
(QALYs) and the VAS scale is less associated with the QALY
paradigm than choice-based valuation methods, like for instance
time trade-off (TTO) [5]. Moreover, the EQ-5D European value
set was based only on data collected in Western European coun-
tries (Finland, Germany, The Netherlands, Spain, Sweden, and
the United Kingdom), lacking data from Poland or any other
Central European country. The primary objective of this study
was therefore to establish a Polish EQ-5D value set using TTO.
The secondary objectives included comparison with the EQ-5D
European VAS value set and other potentially useful value sets, as
well as assessing the possible bias resulting from expanding the
TTO experiment to 23 states per respondent.
Methods
EQ-5D
EQ-5D essentially consists of two pages—the EQ-5D descriptive
system (page 2) and the EQ visual analog scale (EQ VAS) (page
3) [1]. The EQ-5D descriptive system comprises the following
ﬁve dimensions: mobility, self-care, usual activities, pain/
discomfort, and anxiety/depression. Each dimension has three
levels: no problems, some problems, and severe problems. The
respondent is asked to indicate his or her health state by ticking
(or placing a cross) in the box against the most appropriate
statement in each of the ﬁve dimensions. This decision results in
a one-digit number expressing the level selected for that dimen-
sion. A health state is deﬁned by combining one level from each
of the ﬁve dimensions. A total of 243 possible health states are
deﬁned in this way. Each state is referred to in terms of a ﬁve-digit
code. For example, state 11111 indicates no problems on any of
the ﬁve dimensions, while state 11223 indicates no problems
with mobility and self-care, some problems with performing
usual activities, moderate pain or discomfort, and extreme
anxiety or depression.
EQ-5D health states, deﬁned by the EQ-5D descriptive
system, may be converted into a single summary index by apply-
ing a formula that essentially attaches values (also called weights)
to each of the levels in each dimension [6]. The index can be
calculated by deducting the appropriate weights from 1, the
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value for full health (i.e., state 11111). Information in this format
is useful, for example, in cost–utility analysis. Value sets have
been derived for EQ-5D in several countries using the EQ-5D
VAS or the TTO valuation techniques [20].
Sample
Between February and May 2008, 10 trained undergraduated
medical students surveyed a representative sample of the Polish
adult population. Two training workshops for the interviewers
were conducted by two study investigators (JB, DG). Each inter-
viewer had to conduct at least one simulated interview. Survey
quotas with respect to age and sex were prepared based on
demographic data from the Central Statistical Ofﬁce in Poland
[8]. Face-to-face interviews were conducted among visitors of
inpatients in eight medical centers in Warsaw (Mazowieckie
voivodship), Skierniewice (Łódzkie voivodship), and Puławy
(Lubelskie voivodship). Respondents were not promised any
compensation but were given an unexpected gift of limited value
only after the interview had taken place. The study was approved
by the Medical University of Warsaw ethics committee (KB/24/
2008) and all respondents gave informed consent.
Study Design and Pilot Tests
This study was based on the most frequently cited EQ-5D valu-
ation study, the Measurement and Value of Health (MVH), con-
ducted in the United Kingdom in 1993 [9]. The MVH study was
a large exercise, in which each of 3395 respondents valued 13
different health states. The MVH research group collected values
for 43 (out of 245 potential EQ-5D health states [including
“unconscious”]), frequently eliciting more than 500 observations
per health state.
Because of budget limitations of the current study, it was
necessary to modify the MVH protocol. Based on the ﬁndings of
Lamers et al. [10] who studied the efﬁciency of the MVH design,
the current study proposed to 1) carry out approximately 300
interviews; 2) collect approximately 150 valuations per health
state; and 3) increase the number of health states valued per
respondent to more than the 17 health states (as in the EQ-5D
Dutch [10] and Japanese [11] studies).
Five pilot interviews were conducted by one of the study
investigators (DG) and one of the student interviewers. Respon-
dents ranked a set of 19 health states and valued the ranked
health states using the EQ VAS and the TTO technique. These
pilot interviews showed that the ranking and VAS valuation
exercise may be more time-consuming than the TTO exercise
alone. Given that TTO was the primary aim of this study, it was
decided to 1) reduce the number of health states to be valued in
the ranking exercise to 10; 2) reduce the number of ranked health
states to be valued using the EQ VAS to 3 or 4 (the best, the
worst, the closest to the average, “immediate death”); and 3)
increase the number of health states ranked in the TTO exercise
to 23. The above changes were the most substantial deviations
from the MVH protocol. Possible problems resulting from the
increase in the number of states to be valued using TTO, e.g.,
order effects, were addressed using statistical tests (see “MVH
deviations veriﬁcation” section). The data from pilot TTO exer-
cises were included into the ﬁnal study data set.
Interview Procedure
Each respondent was asked to perform the following tasks: 1)
indicate his or her own health status using the EQ-5D descriptive
system; 2) perform the ranking exercise; 3) value the ranked
health states using the EQ-5D VAS; 4) rate his or her own health
on the EQ VAS; 5) perform the TTO exercise; and 6) answer
some socioeconomic background questions. Two sets of 25 cards
describing health states according to the EQ-5D descriptive
system were used alternatingly by the interviewers (Table 1).
Dead and 11111 are not valued in the TTO exercise by its design.
All health states used in the MVH study were used, except
“unconscious.” Two additional health states (23333 and 32333)
were chosen from those proposed by Kind [12]. Cards describing
health states were divided into two ﬁxed sets in such a way that
1) there was equal representation of “very mild,” “mild,” “mod-
erate,” and “severe” health states in both sets; and 2) the largest
number of logical comparisons was allowed (e.g., health states
“11112” and “11113” were included in set 1, while health states
“11121” and “11131” were included in set 2). This procedure
was intended to facilitate ranking by the respondent, to shorten
the survey time and to control data quality. Health states applied
in the ranking exercise (Table 1, states marked with *) were also
selected in the same way to facilitate the survey and shorten the
duration of the preliminary part of the study. Equalization of the
value of health states in both sets used in the ranking exercise was
not a priority. Cards used in the ranking exercise were marked in
the corner on the reverse side by a black dot to allow interviewers
to make a quick selection among the cards in each set. Health
state cards were shufﬂed before the TTO exercise and were
presented in random order. Interviewers were asked not to
present the ﬁrst three cards describing health states worse than
death.
The TTO exercise used the same visual probe as used in the
United Kingdom and in the United States (where researchers also
used a protocol similar to the UK MVH protocol) [9,13]. This
probe, often called a “time board,” allows for both positive and
negative TTO values. The interview book used by Shaw et al.
[14] was translated into Polish and used for training the inter-
Table 1 Sets of health state cards used during the interviews
Health state category Set 1 Set 2
Very mild 11112* 11121*
11211 12111
21111
Mild 11122* 12121
22112 12211
22121*
Moderate 11113* 11131*
11133 11312
12222 12223
13332 13212
21133 13311
21232 21222*
21312 21323
22122* 22222*
22222* 23313
22331 32211
23321 33212
32313 33321*
32331
Severe 22323* 22233
23333 23232
32232 32223
32333* 33232
33333* 33323*
33333*
Anchoring states 11111* 11111*
DE* DE*
States severity was deﬁned following Kind [12]: very mild—one level 2 problem; mild
state—with no level 3 problems and up to three level 2 problems; severe—no level 1
problems and at least two level 3 problems; moderate—neither mild nor severe.
*Cards used in ranking exercise.
DE, death.
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viewers and in the pilot interviews. During these pilot tests, it
emerged that the book was rather complex. For instance, the
description of a single TTO exercise occupied three pages in
English (US) and four pages in the Polish version. Because we had
planned to elicit values for as many as 23 states using TTO, the
TTO valuation task would have taken more than 90 pages.
Moreover, it was considered likely that a 90-page-long protocol
would obstruct the ﬂow of the interview. Based on the interview-
ers’ suggestions and subsequent pilot tests, the instruction and
documentation of the TTO exercise in the protocol book was
reduced to a graphic system, which allowed the registering of
results of ﬁve TTO exercises on a single page (http://www.
ispor.org/Publications/value/ViHsupplementary/ViH13i2_
Golicki.asp). Every interviewer was trained and had continuous
access to a separate instruction standardized on the TTO meth-
odology as carried out in the US study [13].
Respondents were allowed to trade time in months and weeks
instead of years when no valuation changes were noted for a
period of 9 years on side 1 of the time board (positive values).
This was a modiﬁcation introduced during a TTO valuation
study by German EuroQol Group members [15]. Results of the
TTO exercise were read out from the scale in the protocol book
with an accuracy of 0.25 of a year. States regarded as better than
dead were anchored on a scale ranging from full health to dead:
X/10. States regarded as worse than dead were calculated as
X/10 - 1, so scores were bounded by 0 and -1 [9].
Exclusion Criteria
To ensure “rational” trade-offs, respondents who misunderstand
the task were removed [16]. These respondents were identiﬁed
according to the following exclusion criteria: fewer than three
states valued, all states valued worse than dead, all states valued
the same, and “serious logical inconsistencies.” These respon-
dents were distinguished from those who provided “irrational”
values resulting from “normal cognitive imperfections.” A
logical inconsistency was deﬁned as being an instance where one
health state could be clearly seen to be better than another but
the respondent ranked it as worse. A logical inconsistency was
called “serious” if the difference in valuation was greater than
0.5. It was considered a clear sign that the respondent had
misunderstood the task when he or she had 10 or more serious
inconsistencies. In these cases, all responses relating to that par-
ticular respondent were excluded. Extreme values, deﬁned as
values more than 2 SD from the mean, were also excluded.
MVH Deviations Veriﬁcation
One of the aims of the present study was to evaluate the possible
bias resulting from the modiﬁcations made to the original MVH
study design and by expanding the TTO experiment to 23 states
per respondent. We anticipated that respondents might be too
fatigued to credibly answer the last TTO questions. At least two
issues would arise as a result: the mean valuation of a health state
might be different or the variance of this valuation might
increase. In the ﬁrst case, it would pose a problem relating to the
credibility of the valuation; in the second case, the overall error
of estimation might increase.
To assess the possible bias involved, several tests were con-
ducted. First, we tested whether the mean valuation for each
health state differed when it was valued in the middle of the
experiment (as 6th–17th state) or at the end of the experiment (as
18th–23rd state). The ﬁrst ﬁve health states were omitted in this
comparison, because they might have been perceived as a
warm-up task in the TTO experiment. During valuation of ﬁrst
health states, respondents are just learning the rules of TTO
exercise and the variance of the valuation may be signiﬁcantly
high. Beside that, the ﬁrst three states differ from states valued
later, because we asked interviewers not to show states worse
than dead at the beginning of the TTO exercise. Because we
intended to increase the power of the test and minimize the type
II error (not ﬁnding a difference in means when there was one),
a higher than usual signiﬁcance level of P = 0.1 was used. At the
same time, to control for the multiple hypotheses testing for the
44 individual states, we used the Hölm–Bonferroni correction for
multiple hypotheses testing. A t test with separate variance esti-
mation was used, but the common variance assumption did not
change the results. Tests for equality of variances were performed
analogously.
Modeling
The dependent variable was the loss of utility associated with a
speciﬁc health state, i.e., 1 - u, where u is the utility. The predic-
tor variables included binary variables dk,l(j) equal to 1 or 0
depending on whenever level l of domain k of health state j was
1, 2, or 3. Furthermore, we used derived variables described in
earlier EQ-5D valuation studies—N3, D1, I2, I2sq, I3, and I3sq
(for deﬁnitions, see Table 2) [9,13].
The data had the panel structure with one level being the
respondent index, and the other the health state being evaluated.
Two approaches were used in modeling. In the ﬁrst approach, a
simple random effects model was built in. For example, it was
assumed that the loss of utility assigned by i-th respondent to the
j-th health state was described as
Y dl ji j k l i j i
lk
, , ,= + ( ) + +
==
∑∑α α η υ0
2
3
1
5
where a denotes the model parameters, dk,l(j) was deﬁned as
above, hi,j denotes the error term associated with a single TTO
experiment, and ui denotes the error term associated with i-th
respondent (and ﬁxed for this respondent across all TTO experi-
ments). It was assumed that hi,j and ui were independent and
normally distributed with zero means. Additionally, models with
other variables describing the health state j than just dk,l(j) were
used. Random effects modeling was performed with GRETL
software [17].
Table 2 Deﬁnitions of the independent variables used in the analyses
Variable Deﬁnition
MO2 1 if mobility is at level 2; 0 otherwise
MO3 1 if mobility is at level 3; 0 otherwise
SC2 1 if self-care is at level 2; 0 otherwise
SC3 1 if self-care is at level 3; 0 otherwise
UA2 1 if usual activities is at level 2; 0 otherwise
UA3 1 if usual activities is at level 3; 0 otherwise
PD2 1 if pain/discomfort is at level 2; 0 otherwise
PD3 1 if pain/discomfort is at level 3; 0 otherwise
AD2 1 if anxiety/depression is at level 2; 0 otherwise
AD3 1 if anxiety/depression is at level 3; 0 otherwise
N3 1 if any dimension is at level 3; 0 otherwise
D1 Number of movements away from full health beyond the ﬁrst
(ranging from 0 to 4); D1 = max (0; d1,2 + d2,2 + d3,2 + d4,2 +
d5,2 + d1,3 + d2,3 + d3,3 + d4,3 + d5,3 - 1)
D1sq The square of the D1 variable
I2 Number of dimensions at level 2 beyond the ﬁrst
I2 = max (0; d1,2 + d2,2 + d3,2 + d4,2 + d5,2 - 1)
I2sq The square of the I2 variable
I3 Number of dimensions at level 3 beyond the ﬁrst
I3 = max (0; d1,3 + d2,3 + d3,3 + d4,3 + d5,3 - 1)
I3sq The square of the I3 variable
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As a second approach, a more complex random parameters
model was estimated using Bayesian statistics. In this more
complex model, it was assumed that the respondents could differ
not only in the error terms, but also in the model parameters.
This approach allowed for a full incorporation of demographic
differences. The speciﬁcation of a model was as follows:
Y d ji j i k l i k l k l i j
lk
, , , , , , ,= +( ) + +( ) ( ) +
==
∑∑α ε α ε η0 0
2
3
1
5
where a, dk,l(j), and hi,j denote as above, and ei,0 and ei,k,l denote
the random variability of model parameters on the individual
level (notice that ui is incorporated in ei,0 term). It was assumed
that ei,0 and ei,k,l were independent normally distributed random
variables with ﬁxed variance across all respondents. The random
parameters model was estimated using the Bayesian approach
and Markov Chain Monte Carlo (MCMC) method in WinBUGS
software (MRC Biostatistics Unit, Cambridge, UK) [18]. Nonin-
formative priors were used as follows:
α α0 0 1000, ,,k l N∼ ( )
Var Var mean ianceε εi i k l, , ,, , var0 1 1000( ) ( ) = =( )∼ Γ
During the MCMC simulation, 10,000 initial simulations
and 10,000 sample simulations were used. Ninety-ﬁve percent
conﬁdence intervals were calculated using the percentile method.
The quality of the models was assessed on two levels—on the
individual TTO valuation level and on the health state level. On
the individual level, standard R2 coefﬁcient and mean absolute
difference between theoretical and empirical value (mean abso-
lute error [MAE]) were calculated. For all 44 health states used in
the experiment, the mean absolute difference between value pre-
dicted by the given model and average valuation (for the data set
used in modeling) was calculated as well as number of states, for
which this difference was larger than 0.05 or 0.1.
Comparison with Other Countries’ Value Sets
EQ-5D model coefﬁcients and health state values estimated in the
present Polish valuation study were compared with those esti-
mated in other countries. Two TTO and two VAS value sets were
chosen: 1) the United Kingdom TTO value set (MVH A1 [9]) as
it is the “original” standard; 2) the German TTO value set [15]
as it emanates from the country closest geographically to Poland;
3) the European VAS value set [5] as recommended by the
AHTAPol; and 4) the Slovenian VAS [19] as an example of a
country that can be deﬁned as Central European with a similar
political history (although not necessarily sharing cultural simi-
larities with Poland). We performed plain comparison of model
coefﬁcients and calculated the mean absolute difference between
health states values, the number of health states (out of 243) with
values more than 0.05 (or 0.1) different from Polish value, and
the correlation coefﬁcient between value sets.
Results
In total, 321 respondents completed the interview, of which 53%
were females. Age and sex distributions of the respondents after
exclusions are shown in Table 3. The interviewed sample group
was representative of the Polish general population in terms of
age and sex, but contained a large proportion of individuals with
higher education, employed people, and students as well as a low
percentage of widowed individuals. Approximately 62% of
survey participants came from Warsaw, 19% from other towns,
and 15% from rural areas. Overall, 86% of individuals in the
sample group were inhabitants of Mazowieckie voivodship. The
majority of problems reported in the EQ-5D descriptive system
were pain/discomfort (40.1%) or anxiety/depression (37.8%).
The mean health state recorded on the EQ VAS was 81.4 (SD
14.5), and the mean interview time was 42 minutes (SD 13).
There was no response with fewer than three states valued, or
with all states valued worse than dead, or with all states valued
the same. We identiﬁed 532 serious logical inconsistencies in 120
(37%) interviews. Sixteen respondents with 10 or more serious
logical inconsistencies were excluded from the ﬁnal analysis.
These respondents did not differ in demographic characteristics
from the whole sample group. Eleven of the 16 excluded respon-
dents (69%) were interviewed by the same interviewer, suggest-
ing that the surveyor himself might have been the cause of the
logical inconsistencies. Additionally, 206 extreme values, deviat-
ing from the mean score by more than 2 SD, were considered
invalid and were excluded from the analysis. As a result, the
number of useable valuations was reduced from 7351 to 6983 by
excluding the 16 respondents with a high number of serious
logical inconsistencies and, subsequently, to 6777 after excluding
the extreme values (Table 4).
The two ﬁnal models resulted from the random effects mod-
eling are presented in Table 5. The ﬁrst model encompasses all
Table 3 Study sample characteristics compared with the Polish general
population data
Study sample,
after exclusions
(n = 305)
Polish general
population (%)
Male (years) 46.9% 49.9
18–24 7.5% 7.5
25–34 9.8% 11.1
35–44 8.9% 8.7
45–54 9.5% 9.8
55–64 7.5% 7.8
65–74 3.6% 4.1
Female (years) 53.1% 51.1
18–24 7.5% 7.2
25–34 10.5% 10.8
35–44 9.5% 8.5
45–54 10.5% 10.1
55–64 9.5% 8.8
65–74 5.6% 5.7
Mean age (SD) 42.8 (15.7) Not available
Educational level
Low 5.2% 23.7
Middle 52.1% 58.0
High 42.6% 18.3
Marital status
Single 18.4% 20.3
Married/living together 72.1% 64.2
Widowed 4.6% 10.4
Divorced 4.9% 5.1
Work
Employed 62.3% 53.7
Unemployed 3.0% 4.4
Pensioner 3.0% 4.8
Retired 14.8% 14.8
Student 11.1% 6.3
Housewife/househusband 3.9% Not available
Belief in life after death 63.8% Not available
EQ-5D
Those reporting problems on
Mobility 16.8% Not available
Self-care 3.3%
Usual activities 13.8%
Pain/discomfort 40.1%
Anxiety/depression 37.8%
EQ VAS own health
Mean (SD) 81.4 (14.5) Not available
EQ VAS, EQ visual analog scale.
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Table 4 Descriptive statistics on health state level—data before and after quality check
Observed value (data before quality check) Observed value (data after quality check)
Health state
No. of
observations Mean SD
% of
negative
No. of
observations Mean SD
% of
negative
11112 171 0.896 0.212 1 157 0.925 0.116 0
11113 171 0.656 0.425 9 150 0.753 0.250 2
11121 149 0.880 0.206 1 137 0.912 0.132 0
11122 173 0.826 0.287 2 160 0.848 0.249 1
11131 149 0.286 0.619 28 140 0.333 0.595 26
11133 170 0.195 0.648 34 163 0.232 0.630 31
11211 170 0.900 0.168 0 154 0.935 0.091 0
11312 147 0.685 0.362 5 135 0.743 0.246 2
12111 148 0.901 0.168 0 133 0.934 0.100 0
12121 150 0.853 0.203 0 135 0.891 0.140 0
12211 149 0.849 0.178 0 131 0.886 0.129 0
12222 170 0.727 0.356 4 157 0.781 0.237 0
12223 149 0.527 0.462 11 131 0.635 0.304 4
13212 150 0.615 0.403 7 134 0.712 0.234 1
13311 150 0.490 0.513 16 132 0.605 0.373 8
13332 170 -0.071 0.655 49 162 -0.040 0.653 48
21111 170 0.915 0.140 0 156 0.934 0.094 0
21133 170 0.202 0.635 29 162 0.232 0.623 28
21222 149 0.760 0.259 1 137 0.799 0.195 0
21232 170 0.287 0.631 26 160 0.324 0.603 24
21312 170 0.549 0.479 11 151 0.673 0.287 3
21323 149 0.417 0.554 20 133 0.530 0.430 13
22112 170 0.783 0.306 3 156 0.826 0.196 0
22121 149 0.803 0.262 1 140 0.825 0.195 0
22122 170 0.754 0.311 3 155 0.797 0.212 0
22222 319 0.663 0.405 7 290 0.747 0.238 0
22233 150 0.058 0.620 40 142 0.081 0.619 39
22323 172 0.296 0.595 25 158 0.366 0.534 21
22331 171 0.071 0.657 39 163 0.099 0.652 37
23232 149 0.046 0.627 41 141 0.061 0.626 40
23313 149 0.129 0.616 38 141 0.165 0.601 36
23321 173 0.293 0.598 25 160 0.356 0.551 21
23333 169 -0.204 0.626 60 161 -0.213 0.627 62
32211 149 0.464 0.559 19 132 0.573 0.445 13
32223 149 0.187 0.587 34 141 0.216 0.580 32
32232 171 -0.050 0.650 50 163 -0.027 0.645 49
32313 171 0.024 0.653 45 163 0.058 0.647 43
32331 169 -0.110 0.627 53 161 -0.092 0.623 52
32333 172 -0.295 0.597 69 152 -0.384 0.508 74
33212 149 0.278 0.600 29 139 0.319 0.574 27
33232 150 -0.183 0.600 60 142 -0.167 0.607 60
33321 148 0.033 0.648 48 140 0.068 0.640 46
33323 150 -0.150 0.606 55 142 -0.143 0.611 56
33333 318 -0.362 0.542 70 285 -0.461 0.458 78
Total or mean 7351 0.383 0.474 24 6777 0.424 0.411 22
Table 5 Comparison of regression models
Basic I3sq Bayesian
Coefﬁcient (SD) P-value Coefﬁcient (SD) P-value Coefﬁcient (SD) 95% CI
Constant 0.049 (0.018) 0.007 0.035 (0.018) 0.053 0.054 (0.013) 0.028–0.080
MO2 0.052 (0.011) 0.048 (0.011) 0.051 (0.009) 0.035–0.069
MO3 0.331 (0.014) 0.363 (0.016) 0.325 (0.018) 0.289–0.361
SC2 0.054 (0.012) 0.057 (0.012) 0.047 (0.010) 0.028–0.067
SC3 0.235 (0.015) 0.269 (0.016) 0.224 (0.015) 0.196–0.253
UA2 0.046 (0.014) 0.032 (0.014) 0.023 0.048 (0.011) 0.026–0.069
UA3 0.212 (0.014) 0.224 (0.014) 0.212 (0.014) 0.183–0.239
PD2 0.057 (0.011) 0.063 (0.012) 0.058 (0.009) 0.042–0.075
PD3 0.489 (0.012) 0.513 (0.013) 0.485 (0.021) 0.443–0.526
AD2 0.026 (0.013) 0.036 0.030 (0.013) 0.018 0.027 (0.010) 0.007–0.046
AD3 0.207 (0.012) 0.235 (0.013) 0.204 (0.013) 0.179–0.229
I3sq -0.012 (0.002)
R2 overall 0.452 0.452
MAE 0.039 0.033 0.041
No. (of 44) > 0.05 10 12 12
No. (of 44) > 0.10 3 3 3
All coefﬁcients were signiﬁcant at P < 0.001 unless otherwise stated.
CI, conﬁdence interval; MAE, mean absolute error.
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statistically signiﬁcant variables, including I3sq (tested for sig-
niﬁcance of individual variables with t test and the whole set by
F test). The R2 value of the model amounted to 0.4524. Because
this model contains the nonintuitive I3sq variable, it might be
considered as less creditable. Therefore, a second model using
only dk,l variables was estimated. On the other hand, exclusion of
statistically signiﬁcant variables and the correlation with the
other independent variables introduces bias. Nonetheless, the
parsimonious model was much more intuitive and had an R2
value of 0.4517, which is only marginally different from the
saturated model.
Ninety-ﬁve percent conﬁdence intervals for the Bayesian
model excluded zero; thus, all domains on all levels signiﬁcantly
inﬂuenced the utility values (Table 5). In a Bayesian estimation,
R2 was not meaningful and is not reported here. It is also worth
noting that the random parameters modeling results were very
similar to the random effects modeling, indicating that the het-
erogeneity of the surveyed population had generally no impact
on the results. Because Bayesian modeling resulted in no extra
predictive value (MAE of 0.039 for the parsimonious model vs.
0.041 for the random parameters model), we therefore decided
to base the Polish value set on the classical random effects model,
with only dk,l variables and without any interaction variables.
The ﬁnal full Polish EQ-5D value set is presented in Table 6.
Test of Additional TTO Valuations
The comparison of health state values when assigned during the
middle of the experiment (position 6 to 17) or at the end (posi-
tion 18 to 23) showed no statistically signiﬁcant differences
neither in mean nor in variance using the Hölm–Bonferroni
correction (the smallest P-values for means and variances com-
parison between groups were equal to 0.0161 and 0.006, respec-
tively, with Hölm–Bonferroni threshold of 0.002273). The
results are shown in Table 7 (the values have been ordered
according to P-values in variance testing). We therefore inferred
that additional states were credibly valued (with identical means)
and increased the precision of the ﬁnal estimation (i.e., did not
inﬂate the total variance). Hence, the extension of the number of
states was justiﬁable.
Comparison with Other Countries’ Value Sets
In a comparison of estimated values, for all health states, it can
be seen that the Polish TTO values are higher than the UK values
from the MVH survey (Fig. 1a) and were similar to the German
TTO values, although estimation of individual states differed
(Fig. 1b). Comparison with the European and Slovenian value
sets showed the classical pattern of differences between TTO and
VAS values, with Polish TTO values higher for the better health
states and lower for the worse health states (Fig. 1c,d).
Table 8 presents a statistical summary of cross-country com-
parisons. Polish health state values correlate signiﬁcantly with
UK values from the MVH A1 value set (R2 = 0.90), but at the
same time, mean absolute difference between Polish and UK
values is the largest (0.245, compared with 0.117 between Polish
and German values).
Discussion
In this study, we performed 321 face-to-face TTO interviews,
directly measuring population values for 44 EQ-5D health states
and estimated the Polish EQ-5D value set using random effects
modeling.
The Polish EQ-5D valuation study differed in several aspects
from the original UK MVH protocol. First, we reduced the
ranking exercise to 10 health states and nearly eliminated the
VAS valuation of ranked health states (four states) while increas-
ing the number of health states to 23 valued in the TTO exercise.
To date, this is the highest number of health states per respondent
valued in a national valuation study. Second, similar to valuation
studies performed in The Netherlands [10] and in Japan [11],
predetermined health state sets were used; yet, in contrast to the
before-mentioned studies, there were two sets, not one. Third, we
developed a detailed description of the TTO exercise in a sepa-
rate instruction booklet, leaving the graphic form of recording
Table 6 Polish EQ-5D value set
State Utility State Utility State Utility State Utility
11111 1.000 13132 0.201 22223 0.535 31321 0.351
11112 0.925 13133 0.020 22231 0.310 31322 0.325
11113 0.744 13211 0.670 22232 0.284 31323 0.144
11121 0.894 13212 0.644 22233 0.103 31331 -0.081
11122 0.868 13213 0.463 22311 0.633 31332 -0.107
11123 0.687 13221 0.613 22312 0.607 31333 -0.288
11131 0.462 13222 0.587 22313 0.426 32111 0.566
11132 0.436 13223 0.406 22321 0.576 32112 0.540
11133 0.255 13231 0.181 22322 0.550 32113 0.359
11211 0.905 13232 0.155 22323 0.369 32121 0.509
11212 0.879 13233 -0.026 22331 0.144 32122 0.483
11213 0.698 13311 0.504 22332 0.118 32123 0.302
11221 0.848 13312 0.478 22333 -0.063 32131 0.077
11222 0.822 13313 0.297 23111 0.664 32132 0.051
11223 0.641 13321 0.447 23112 0.638 32133 -0.130
11231 0.416 13322 0.421 23113 0.457 32211 0.520
11232 0.390 13323 0.240 23121 0.607 32212 0.494
11233 0.209 13331 0.015 23122 0.581 32213 0.312
11311 0.739 13332 -0.011 23123 0.400 32221 0.463
11312 0.713 13333 -0.192 23131 0.175 32222 0.437
11313 0.532 21111 0.899 23132 0.149 32223 0.256
11321 0.682 21112 0.873 23133 -0.032 32231 0.031
11322 0.656 21113 0.692 23211 0.618 32232 0.005
11323 0.475 21121 0.842 23212 0.592 32233 -0.176
11331 0.250 21122 0.816 23213 0.411 32311 0.354
11332 0.224 21123 0.635 23221 0.561 32312 0.328
11333 0.043 21131 0.410 23222 0.535 32313 0.147
12111 0.897 21132 0.384 23223 0.354 32321 0.297
12112 0.871 21133 0.203 23231 0.129 32322 0.270
12113 0.690 21211 0.853 23232 0.103 32323 0.090
12121 0.840 21212 0.827 23233 -0.078 32331 -0.135
12122 0.814 21213 0.646 23311 0.452 32332 -0.161
12123 0.633 21221 0.796 23312 0.426 32333 -0.342
12131 0.408 21222 0.770 23313 0.245 33111 0.385
12132 0.382 21223 0.589 23321 0.395 33112 0.359
12133 0.201 21231 0.364 23322 0.369 33113 0.178
12211 0.851 21232 0.338 23323 0.188 33121 0.328
12212 0.825 21233 0.157 23331 -0.037 33122 0.302
12213 0.644 21311 0.687 23332 -0.063 33123 0.121
12221 0.794 21312 0.661 23333 -0.244 33131 -0.104
12222 0.768 21313 0.480 31111 0.620 33132 -0.130
12223 0.587 21321 0.630 31112 0.594 33133 -0.311
12231 0.362 21322 0.604 31113 0.413 33211 0.339
12232 0.336 21323 0.423 31121 0.563 33212 0.313
12233 0.155 21331 0.198 31122 0.537 33213 0.132
12311 0.685 21332 0.172 31123 0.356 33221 0.282
12312 0.659 21333 -0.009 31131 0.131 33222 0.256
12313 0.478 22111 0.845 31132 0.105 33223 0.075
12321 0.628 22112 0.819 31133 -0.076 33231 -0.150
12322 0.602 22113 0.638 31211 0.574 33232 -0.176
12323 0.421 22121 0.788 31212 0.548 33233 -0.357
12331 0.196 22122 0.762 31213 0.367 33311 0.173
12332 0.170 22123 0.581 31221 0.517 33312 0.147
12333 -0.011 22131 0.356 31222 0.491 33313 -0.034
13111 0.716 22132 0.330 31223 0.310 33321 0.116
13112 0.690 22133 0.149 31231 0.085 33322 0.090
13113 0.509 22211 0.799 31232 0.059 33323 -0.091
13121 0.659 22212 0.773 31233 -0.122 33331 -0.316
13122 0.633 22213 0.592 31311 0.408 33332 -0.342
13123 0.452 22221 0.742 31312 0.382 33333 -0.523
13131 0.227 22222 0.716 31313 0.201 Dead 0.000
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the TTO results in the protocol book. Additionally, we conﬁrmed
the results of random effects modeling in random parameters
modeling (using the Bayesian approach), proving that heteroge-
neity of the surveyed population had no inﬂuence on the results.
The limited number of respondents can be regarded as a
potential weakness of our study, although the size of the sample
group is similar to the sample size in the German [15] and Dutch
[10] valuation studies. The sample size proved to be sufﬁcient in
obtaining statistically signiﬁcant model coefﬁcients. Another
important weakness of our study may be lack of formal random
allocation of responders to our study population. The represen-
tativeness of the sample was controlled with respect to two
characteristics—age and sex—through quotas. Of course the
sample is not representative with respect to other features: edu-
cation, geography, or having a relative/friend inpatient. It is
difﬁcult to state a priori whether this characteristics impact the
preferences among health states. On one hand, it can be argued
that it can impact the preferences depending on the relative’s
illness; on the other, it may increase the awareness of the respon-
dent and improve the quality of the results. Although patient
relatives may not be an ideal population for valuation exercise,
they were interviewed in earlier valuation studies in Spain and
Argentina [20,21]. Our highly educated study sample, although
not representative for general population, may better compre-
hend and perform TTO exercise, making the results more con-
sistent and credible, and actually improve goodness of ﬁt.
Nevertheless, it may be the case that the highly educated differ
from worse educated in the preferences among health states
either directly or indirectly via another characteristics (e.g.,
increased wealth). In this case, our results would be biased.
Because there were no previous health surveys using EQ-5D in
Poland, it is unlikely to assess the representativeness and
compare our study sample with the Polish general population
considering health status data. This line of research should be
pursued in the following studies.
Finally, by using fewer interviewers, we would probably
have improved the quality of data, but for practical reasons, we
were unable to reduce their number below 10. Despite these
limitations, goodness-of-ﬁt analysis proved that direct utilities
from surveys ﬁt the model-derived utilities relatively well with
R2 of 0.45, which is close to 0.46 obtained in the MVH study
[9].
Table 7 Equality of mean and variance tests for evaluations in the middle vs. at the end of the time trade-off experiment
State
In position 6th–17th In position 18th–23rd P-value for equality
of variance test
P-value for equality
of mean testN Mean (SD) N Mean (SD)
12223 97 0.482 (0.511) 36 0.627 (0.235) 0.0060 0.0278
22112 80 0.856 (0.196) 33 0.704 (0.323) 0.0062 0.0161
22323 102 0.279 (0.56) 41 0.174 (0.694) 0.0282 0.3911
11312 63 0.659 (0.439) 50 0.742 (0.246) 0.0411 0.2057
13212 69 0.546 (0.501) 47 0.68 (0.289) 0.0597 0.0702
23321 102 0.309 (0.579) 52 0.202 (0.655) 0.1040 0.3206
21133 98 0.154 (0.65) 50 0.383 (0.591) 0.2232 0.0337
32313 106 0.044 (0.625) 40 -0.042 (0.683) 0.2405 0.4937
23232 81 -0.001 (0.676) 40 0.006 (0.59) 0.2496 0.9547
12211 66 0.863 (0.165) 29 0.839 (0.205) 0.2651 0.5883
11122 68 0.834 (0.192) 47 0.785 (0.397) 0.3050 0.4419
33212 94 0.262 (0.604) 40 0.347 (0.554) 0.3200 0.4287
21111 80 0.932 (0.109) 30 0.905 (0.169) 0.3264 0.4206
33323 75 -0.106 (0.595) 47 -0.19 (0.647) 0.3708 0.4718
22331 109 0.081 (0.68) 43 0.048 (0.626) 0.3979 0.7761
22122 66 0.741 (0.369) 49 0.769 (0.249) 0.4051 0.6307
32223 80 0.141 (0.59) 48 0.26 (0.575) 0.4301 0.2632
21232 89 0.311 (0.631) 53 0.144 (0.658) 0.4500 0.1400
22222 151 0.671 (0.378) 91 0.613 (0.437) 0.4626 0.2922
32333 90 -0.374 (0.574) 49 -0.277 (0.578) 0.4784 0.3435
32232 87 -0.087 (0.642) 62 -0.047 (0.69) 0.4806 0.7222
11133 102 0.208 (0.638) 45 0.169 (0.684) 0.5035 0.7473
13332 106 -0.1 (0.643) 42 0.029 (0.7) 0.5391 0.3080
11113 91 0.666 (0.403) 47 0.658 (0.449) 0.5941 0.9236
33232 88 -0.142 (0.603) 45 -0.266 (0.581) 0.6072 0.2538
11211 70 0.919 (0.169) 38 0.93 (0.087) 0.6145 0.6455
13311 85 0.51 (0.534) 37 0.497 (0.484) 0.6186 0.8958
21222 74 0.716 (0.263) 35 0.776 (0.303) 0.6453 0.3140
21312 86 0.518 (0.503) 51 0.548 (0.475) 0.6605 0.7319
11121 47 0.866 (0.254) 35 0.851 (0.224) 0.6729 0.7844
11112 61 0.932 (0.102) 37 0.942 (0.122) 0.6751 0.6629
12111 58 0.887 (0.194) 19 0.908 (0.198) 0.6751 0.6946
11131 81 0.328 (0.606) 36 0.188 (0.656) 0.7216 0.2815
33321 97 0.034 (0.623) 36 -0.073 (0.657) 0.7608 0.3984
33333 171 -0.357 (0.568) 104 -0.358 (0.515) 0.7611 0.9873
21323 89 0.437 (0.545) 43 0.471 (0.55) 0.7744 0.7393
22233 91 0.004 (0.599) 47 0.131 (0.652) 0.8198 0.2675
22121 70 0.803 (0.282) 23 0.793 (0.215) 0.8251 0.8522
32211 91 0.471 (0.531) 32 0.522 (0.558) 0.8261 0.6504
23333 99 -0.224 (0.638) 36 -0.25 (0.663) 0.8477 0.8411
12121 62 0.862 (0.199) 30 0.83 (0.218) 0.9053 0.4989
12222 86 0.74 (0.364) 37 0.712 (0.37) 0.9309 0.6982
23313 87 0.149 (0.61) 43 0.195 (0.599) 0.9459 0.6814
32331 106 -0.093 (0.622) 37 -0.243 (0.643) 0.9901 0.2228
All 3851 0.326 (0.649) 1912 0.33 (0.651) 0.9487 0.8028
The smallest value in each P-value column has been put in bold.The minimal Hölm–Bonferroni threshold amounts to 0.0023.
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Moreover, we believe that the present study supports the use
of more health states in TTO experiments than previously
thought. We found no statistical differences neither in mean nor
in variance between valuations when a given health state was
valued as 6th–17th in a row or 18th–23rd. Therefore, there is no
risk of a bias or efﬁciency decrease in the estimation. This ﬁnding
provides evidence for improving the efﬁciency of valuation pro-
tocols and supports the estimation of national value sets in other
countries, including Central and Eastern Europe.
In the Polish version of EQ-5D, as in the Dutch and Italian
versions, the wording chosen for the third level of “mobility,”
“conﬁned to bed,” implies being bedridden. Some of the
authors were concerned that this could have caused the Polish
values to be lower for health states that included the third level
of “mobility” [7]. In comparing dimensions (based on level 3
coefﬁcients and assuming no other problems), individuals in
Poland, similar to those in the United Kingdom and Zimbabwe,
valued problems associated with “pain/discomfort” as the
worst and not the problems associated with “mobility,” as in
Argentina, Denmark, Germany, Japan, Spain, the United States,
and Spanish-speaking Hispanic US residents [2]. In Poland,
similar to Argentina and the Spanish-speaking Hispanic US
Figure 1 Graphical comparison of Polish EQ-5DTTO value set versus: (a) UKTTO, (b) GermanTTO, (c) EuropeanVAS, and (d) SlovenianVAS value set.TTO, time
trade-off;VAS, visual analog scale.
Table 8 Comparison of coefﬁcients in Polish and selected European models
Polish TTO UK TTO (MVH A1) German TTO European VAS Slovenian VAS
Constant 0.049 0.081 0.001 0.1279 0.128
MO2 0.052 0.069 0.099 0.0659 0.206
MO3 0.331 0.314 0.327 0.1829 0.412
SC2 0.054 0.104 0.087 0.1173 0.093
SC3 0.235 0.214 0.174 0.1559 0.186
UA2 0.046 0.036 0.0264 0.054
UA3 0.212 0.094 0.0860 0.108
PD2 0.057 0.123 0.112 0.0930 0.111
PD3 0.489 0.386 0.315 0.1637 0.222
AD2 0.026 0.071 0.0891 0.093
AD3 0.207 0.236 0.065 0.1290 0.186
N3 0.269 0.323 0.2288
Mean absolute difference 0.245 0.117 0.167 0.146
No. (of 243) > 0.05 vs. Polish 238 (98%) 178 (73%) 210 (86%) 193 (79%)
No. (of 243) > 0.10 vs. Polish 219 (90%) 122 (50%) 178 (73%) 147 (60%)
R2 vs. Polish 0.90 0.81 0.74 0.73
MVH, Measurement and Value of Health;TTO, time trade-off;VAS, visual analog scale.
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residents, the “anxiety/depression” domain was ranked as the
least important [21,22]. This differs from other countries
where the “usual activities” domain was judged the least
important.
Conclusions
This is the ﬁrst EQ-5D value set based on TTO in Central and
Eastern Europe so far. Because the values differ considerably
from those elicited in Western European countries, its use should
be recommended for studies in Poland. Increasing the number of
health states that each respondent is asked to value using TTO
seems feasible and justiﬁable.
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